Radithia D,
Subarnbhesaj A, Ayuningtyas NF, Bakti RK, Mahdani FY, Pratiwi AS, Ayunnisa N,
Putri SF, Pramitha SR. Oral hyperpigmentation as an adverse effect of highly
active antiretroviral therapy in HIV patients: A systematic review and pooled
prevalence. J Clin Exp Dent. 2023;15(7):e561-70.
doi:10.4317/jced.60195
https://doi.org/10.4317/jced.60195
__________
References
1.
Rumbwere Dube BN, Marshall TP, Ryan RP, Omonijo M. Predictors of human
immunodeficiency virus (HIV) infection in primary care among adults living in
developed countries: A systematic review. Syst Rev. 2018;7. |
|
|
|
2.
Rao KVSE, Chitturi RT, Kattappagari KK, Kantheti LPC, Poosarla C, Baddam VRR.
Impact of highly active antiretroviral therapy on oral manifestations of
patients with human immunodeficiency virus/acquired immuno deficiency
syndrome in South India. Indian J Sex Transm Dis. 2015;36:35-9. |
|
|
|
3.
Patil N, Chaurasia VR, Babaji P, Ramesh D, Jhamb K. SAM. The effect of highly
active antiretroviral therapy on the prevalence of oral manifestation in
human immunodeficiency virus- infected patients in Karnataka, India. Eur J
Dent. 2015;9:47-52. |
|
|
|
4.
Parekh BS, Ou CY, Fonjungo PN, Kalou MB, Rottinghaus E, Puren A, et al.
Diagnosis of Human Immunodeficiency Virus Infection. Clin Microbiol Rev.
2018;32:1-55. |
|
|
|
5.
Feria MG, Taborda NA, Hernandez JC, Rugeles MT. HIV replication is associated
to inflammasomes activation, IL-1β, IL-18 and caspase-1 expression in GALT
and peripheral blood. PLoS One. 2018;13:1-14. |
|
|
|
6.
Nittayananta W, Talungchit S, Jaruratanasirikul S, Silpapojakul K, Chayakul
P, Nilmanat APN. Effects of long-term use of HAART on oral health status of
HIV- infected subjects. J Oral Pathol Med. 2010;39:397-406. |
|
|
|
7.
Reeves DB, Duke ER, Wagner TA, Palmer SE, Spivak AM, Schiffer JT. A majority
of HIV persistence during antiretroviral therapy is due to infected cell proliferation.
Nat Commun. 2018;9. |
|
|
|
8.
Vella S, Schwartländer B, Sow SP, Eholie SP, Murphy RL. The history of
antiretroviral therapy and of its implementation in resource-limited areas of
the world. Aids. 2012;26:1231-41. |
|
|
|
9.
Ponnam SR, Srivastava G, Theruru K. Oral manifestations of human
immunodeficiency virus in children: An institutional study at highly active
antiretroviral therapy centre in India. J Oral Maxillofac Pathol. 2012;16:195-202. |
|
|
|
10.
Satyakiran G, Bavle R, Alexander G, Rao S, Venugopal R, Hosthor S. A
relationship between CD4 count and oral manifestations of human
immunodeficiency virus-infected patients on highly active antiretroviral
therapy in urban population. J Oral Maxillofac Pathol. 2016;20:419-26. |
|
|
|
11.
Abe OE, Fagbule OF, Olaniyi OO, Adisa AO, Gbolahan OO,. Orofacial lesions
associated with long-term highly active antiretroviral therapy among hiv-seropositive
adults in ibadan, nigeria. Pan Afr Med J. 2021;38. |
|
|
|
12.
Binmadi NO, Bawazir M, Alhindi N, Mawardi H, Mansour G, Alhamed S, et al.
Medication- induced oral hyperpigmentation: A systematic review. Patient
Prefer Adherence. 2020;14:1961- 8. |
|
|
|
13.
Abduljabbar T, Vohra F, Akram Z, Ghani SMA, Al-Hamoudi N, Javed F. Efficacy
of surgical laser therapy in the management of oral pigmented lesions: A
systematic review. J Photochem Photobiol B Biol. 2017;173:353-9. |
|
|
|
14.
Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al.
The PRISMA 2020 statement: An updated guideline for reporting systematic
reviews. BMJ. 2021;372:2020-1. |
|
|
|
15.
Modesti PA, Reboldi G, Cappuccio FP, Agyemang C, Remuzzi G, Rapi S, et al.
Panethnic differences in blood pressure in Europe: A systematic review and meta-analysis.
PLoS One. 2016;11:1-21. |
|
|
|
16.
Herzog R, Álvarez-Pasquin MJ, Díaz C, Del Barrio JL, Estrada JM, Gil Á. Are
healthcare workers intentions to vaccinate related to their knowledge,
beliefs and attitudes? A systematic review. BMC Public Health. 2013;13. |
|
|
|
17.
Anchala R, Kannuri NK, Pant H, Khan H, Franco OH, Di Angelantonio E, et al.
Hypertension in India: A systematic review and meta-analysis of prevalence,
awareness, and control of hypertension. J Hypertens. 2014;32:1170-7. |
|
|
|
18.
Alosh M, Huque MF, Koch GG. Statistical Perspectives on Subgroup Analysis:
Testing for Heterogeneity and Evaluating Error Rate for the Complementary
Subgroup. J Biopharm Stat. 2015;25:1161-78. |
|
|
|
19.
Umadevi KMR, Ranganathan K, Pavithra S, Hemalatha R, Saraswathi TR,
Kumarasamy N, et al. Oral lesions among persons with HIV disease with and
without highly active antiretroviral therapy in southern India. J Oral Pathol
Med. 2007;36:136-41. |
|
|
|
20.
Lam-ubol A, Rungsiyanont S, Vacharotayangul P, Sappayatosok K, Chankanka O.
Oral manifestations, salivary flow rates and Candida species in Thai
HIV-infected patients. J Clin Exp Dent. 2019;11:e138-45. |
|
|
|
21.
Hamza OJM, Matee MIN, Simon ENM, Kikwilu E, Moshi MJ, Mugusi F, et al. Oral
manifestations of HIV infection in children and adults receiving highly
active anti-retroviral therapy [HAART] in Dar es Salaam, Tanzania. BMC Oral
Health. 2006;6:1-9. |
|
|
|
22.
Mary EO, Abiola OA, Titilola G, Mojirayo OO, Sulaimon AA. Prevalence of HIV
related oral lesions in people living with HIV and on combined antiretroviral
therapy: A Nigerian experience. Pan Afr Med J. 2018;31:1-10. |
|
|
|
23.
Denny CE, Ramapuram J, Bastian TS, Binnal A, Natarajan S, Sujir N. Oral and
systemic comorbidities and its relation to cluster of differentiation 4
counts in human immunodeficiency virus patients on highly active
antiretroviral therapy: An observational study. World J Dent. 2019;10:275-9. |
|
|
|
24.
Naidu SG, Thakur R, Singh AK, Rajbhandary S, Mishra RK, Sagtani A. Oral
lesions and immune status of HIV infected adults from eastern Nepal. J Clin
Exp Dent. 2013;5:1-7. |
|
|
|
25.
Sreeja C, Ramakrishnan K, Vijayalakshmi D, Devi M, Aesha I, Vijayabanu B.
Oral pigmentation: A review. J Pharm Bioallied Sci. 2015;7:S403-8. |
|
|
|
26.
Lu DY, Wu HY, Yarla NS, Xu B, Ding J, Lu TR. HAART in HIV/AIDS Treatments:
Future Trends. Infect Disord - Drug Targets. 2017;18(1):15-22. |
|
|
|
27.
Shoubin M, Kandasamy M, Gopalan K, Vellaisamy SG, Manickam N.
Zidovudine-induced pigmentation on skin, nail and oral cavity - A study on
119 patients. J Pakistan Assoc Dermatologists. 2018;28:351-4. |
|
|
|
28.
Mallagray-Montero MDC, Moreno-López LA, Cerero-Lapiedra R, Castro-Janeiro M,
Madrigal- Martínez-pereda C,. Medication related to pigmentation of oral
mucosa. Med Oral Patol Oral y Cir Bucal. 2022;27:e230-7. |
|
|
|
29.
Schank M, Zhao J, Moorman JP, Yao ZQ. The impact of hiv-and art-induced
mitochondrial dysfunction in cellular senescence and aging. Cells.
2021;10:1-21. |
|
|
|
30.Denat
L., Kadekaro A. L., Marrot L., Leachman S. A-MZA. Melanocytes as Instigators
and Victims of Oxidative Stress. J Invest Dermatol. 2014;134:1512-8. |
|
|
|
31.
Swope VB, Abdel-Malek ZA. Significance of the melanocortin 1 and endothelin B
receptors in melanocyte homeostasis and prevention of sun-induced genotoxicity.
Front Genet. 2016;7:1-11. |
|
|
|
32.
Doleman B, Freeman SC, Lund JN, Williams JP, Sutton AJ. Funnel plots may show
asymmetry in the absence of publication bias with continuous outcomes
dependent on baseline risk: presentation of a new publication bias test. Res
Synth Methods. 2020;11:522-34. |
|
|
|
33.
Chandran R, Feller L, Lemmer J, Khammissa RAG. HIV-Associated Oral Mucosal
Melanin Hyperpigmentation: A Clinical Study in a South African Population
Sample. AIDS Res Treat. 2016;2016. |
|
|
|
34.
Rosebush MS, Briody AN, Cordell KG. Black and Brown: Non-neoplastic
Pigmentation of the Oral Mucosa. Head Neck Pathol [Internet]. 2019;13:47-55. |
|
|
|
35.
Feller L, Masilana A, Khammissa RAG, Altini M, Jadwat Y, Lemmer J. Melanin:
The biophysiology of oral melanocytes and physiological oral pigmentation.
Head Face Med [Internet]. 2014;10:1-7. |
|
|
|
36.
Lock JY, Carlson TL, Wang CM, Chen A, Carrier RL. Acute Exposure to Commonly
Ingested Emulsifiers Alters Intestinal Mucus Structure and Transport
Properties. Sci Rep. 2018;8:1- 14. |
|
|
|
37.
Singh S, Rai T. A case of zidovudine induced pigmentation on palms and soles.
Indian Dermatol Online J. 2014;5:98. |
|
|
|
38.
Moreiras H, Seabra MC, Barral DC. Melanin transfer in the epidermis: The
pursuit of skin pigmentation control mechanisms. Int J Mol Sci. 2021;22. |
|
|
|
39.
Giménez García RM, Molina SC. Drug-induced hyperpigmentation: Review and case
series. J Am Board Fam Med. 2019;32:628-38. |
|
|
|
40.
Von Hippel PT. The heterogeneity statistic I2 can be biased in small
meta-analyses. BMC Med Res Methodol. 2015;15:1-8. |